Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against Staphylococcus aureus planktonic and biofilm growth

Journal of Antibiotics

Volumn 69, Issue 9, 2016, Pages 689-696

  Kifer, Domagoj ^a   Mužinić, Vedran ^a   Klaric, Maja Šegvic ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CINEOLE; MENTHOL; PSEUDOMONIC ACID; TERPENE; THYMOL; ANTIINFECTIVE AGENT; CYCLOHEXANOL DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; COMPARATIVE STUDY; DRUG EFFECTS; DRUG POTENTIATION; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BIOFILMS; CYCLOHEXANOLS; DRUG SYNERGISM; MENTHOL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MONOTERPENES; MUPIROCIN; PLANKTON; STAPHYLOCOCCUS AUREUS; THYMOL;

EID: 84988884718     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2016.10     Document Type: Article

References (48)

1. Reiß, S. et al. Global analysis of the Staphylococcus aureus response to mupirocin. Antimicrob. Agents Chemother. 56, 787-804 (2012).
2. Brook, I. The role of bacteria in chronic rhinosinusitis. Otolaryngologic Clinics of North America 38, 1171-1192 (2005).
3. Lin, A., Busaba, N. Y. Staphylococcus aureus and endoscopic sinus surgery. Curr. Opin. Otolaryngol. Head Neck Surg. 14, 19-22 (2006).
4. Kilty, S. J., Desrosiers, M. Y. The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr. Allergy Asthma Rep. 8, 227-233 (2008).
5. Hall-Stoodley, L. et al. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95-108 (2004).
6. Lewis,K.Riddleofbiofilm resistance. Antimicrob. Agents Chemother. 45, 999-1007 (2001).
7. Fux, C. A., Stoodley, P., Hall-Stoodley, L., Costerton, J. W. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti. Infect. Ther. 1, 667-683 (2003).
8. Keir, J., Pedelty, L., Swift, A. C. Biofilms in chronic rhinosinusitis: systematic review and suggestions for future research. J. Laryngol. Otol. 125, 331-337 (2011).
9. Hughes, J., Mellows, G. Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem. J. 191, 209-219 (1980).
10. Thomas, C. M., Hothersall, J., Willis, C. L., Simpson, T. J. Resistance to and synthesis of the antibiotic mupirocin. Nat. Rev. Microbiol. 8, 281-289 (2010).
11. Bode, L. G. M. et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362, 9-17 (2010).
12. Simões, M., Bennett, R. N., Rosa, E. A. S. Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat. Prod. Rep. 26, 746-757 (2009).
13. Nccls Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute-NCCLS 27 (2007).
14. Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J., Wink, M. Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens. Phytomedicine 17, 1061-1066 (2010).
15. Walencka, E., Sadowska, B., Rózalska, S., Hryniewicz, W., Rózalska, B. Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Polish J. Microbiol 54, 191-200 (2005).
16. Kairo, S. K., Bedwell, J., Tyler, P. C., Carter, A., Corbel, M. J. Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines. Vaccine 17, 2423-2428 (1999).
17. Chou, T.-C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621-681 (2006).
18. Sutherland, R. et al. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob. Agents Chemother. 27, 495-498 (1985).
19. Kresken, M., Hafner, D., Schmitz, F. J., Wichelhaus, T. A. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: Results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Int. J. Antimicrob. Agents 23, 577-581 (2004).
20. Dürrigl, M. et al. Spray dried microparticles for controlled delivery of mupirocin calcium: process-tailored modulation of drug release. J. Microencapsul. 28, 108-121 (2011).
21. Wattanasatcha, A., Rengpipat, S., Wanichwecharungruang, S. Thymol nanospheres as an effective anti-bacterial agent. Int. J. Pharm. 434, 360-365 (2012).
22. Trombetta, D. et al. Mechanisms of antibacterial action of three monoterpenes mechanisms of antibacterial action of three monoterpenes. J. Antimicrob. Agents Chemother. 49, 2474-2478 (2005).
23. Guarda, A., Rubilar, J. F., Miltz, J., Galotto, M. J. The antimicrobial activity of microencapsulated thymol and carvacrol. Int. J. Food Microbiol. 146, 144-150 (2011).
24. Hendry, E. R., Worthington, T., Conway, B. R., Lambert, P. A. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J. Antimicrob. Chemother. 64, 1219-1225 (2009).
25. Capobianco, J. O., Doran, C. C., Goldman, R. C. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob. Agents Chemother. 33, 156-163 (1989).
26. Hurler, J., Sørensen, K. K., Fallarero, A., Vuorela, P., Škalko-Basnet, N. Liposomes-inhydrogel delivery system with mupirocin: In vitro antibiofilm studies and in vivo evaluation in mice burn model. Biomed. Res. Int. 2013, 498485 (2013).
27. Kwieci?ski, J., Eick, S., Wójcik, K. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int. J. Antimicrob. Agents 33, 343-347 (2009).
28. Pettit, R. K. et al. Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob. Agents Chemother. 49, 2612-2617 (2005).
29. Merritt, J. H., Kadouri, D. E., O'Toole, G. A. Growing and analyzing static biofilms. Curr. Protoc. Microbiol (2005) Chapter 1: Unit 1B.1
30. O'Toole, G. A. Microtiter dish biofilm formation assay. J. Vis. Exp. 47, 2437 (2011).
31. Ceri, H. et al. The Calgary Biofilm Device : new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms the calgary biofilm device : new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37, 1771 (1999).
32. Ha, K. R., Psaltis, A. J., Butcher, A. R., Wormald, P.-J., Tan, L. W. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 118, 535-540 (2008).
33. Nostro, A. et al. Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Med. Microbiol. 56, 519-523 (2007).
34. Mah, T. F. C., O'Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34-39 (2001).
35. Sepandj, F., Ceri, H., Gibb, A., Read, R., Olson, M. Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis [1]. Perit. Dial. Int. 27, 464-465 (2007).
36. Braga, P. C., Dal Sasso, M., Culici, M., Spallino, A. Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study. Arzneimittelforschung 60, 675-681 (2010).
37. Husain, F. M. et al. Sub-MICs of Mentha piperita essential oil and menthol inhibits AHL mediated quorum sensing and biofilm of Gram-negative bacteria. Front. Microbiol. 6, 1-12 (2015).
38. Masadeh, M. M., Gharaibeh, S. F., Alzoubi, K. H., Al-Azzam, S. I., Obeidat, W. M. Antimicrobial activity of common mouthwash solutions on multidrug-resistance bacterial biofilms. J. Clin. Med. Res. 5, 389-394 (2013).
39. El Abed, S. et al. Carvacrol and thymol components inhibiting Pseudomonas aeruginosa adherence and biofilm formation. Afr. J. Microbiol. Res. 5, 3229-3232 (2011).
40. Griffin, S., Wyllie, S. G., Markham, J. Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography. J. Chromatogr. A 864, 221-228 (1999).
41. Weber, F. J., De Bont, J. A. M. Adaptation mechanisms of microorganisms to the toxic effects of organic solvents on membranes. Biochim. Biophys. Acta. Rev. Biomembr 1286, 225-245 (1996).
42. Maffei, M., Camusso, W., Sacco, S. Effect of Mentha x piperita essential oil and monoterpenes on cucumber root membrane potential. Phytochemistry 58, 703-707 (2001).
43. Knowles, J. R., Roller, S., Murray, D. B., Naidu, A. S. Antimicrobial action of carvacrol at different stages of dual-species biofilm development by Staphylococcus aureus and Salmonella enterica serovar Typhimurium. Appl. Env. Microbiol 71, 797-803 (2005).
44. Prince, A. et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am. J. Rhinol. 22, 239-245 (2008).
45. Juergens, U. R., Stöber, M., Schmidt-Schilling, L., Kleuver, T., Vetter, H. Antiinflammatory effects of euclyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo. Eur. J. Med. Res. 3, 407-412 (1998).
46. Bhatia, S. P., McGinty, D., Letizia, C. S., Api, A.,M. Fragrance material review on dihydro l-menthol. Food Chem. Toxicol. 46, S218-S223 (2008).
47. Basch, E., Basch, E., Bevins, A., Sollars, D. Thyme (Thymus vulgaris L.), Thymol. J. Herb. Pharmacother. 4, 49-67 (2004).
48. De Cássia, Da Silveira, E., Sá, R., Andrade, L. N., De Sousa, D. P. A review on anti-inflammatory activity of monoterpenes. Molecules 18, 1227-1254 (2013).